Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia

It is believed that there are key differences in the genomic profile between adult and childhood acute myeloid leukemia (AML). Relapse is the significant contributor of mortality in patients with AML and remains as the leading cause of cancer death among children, posing great challenges in the trea...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Habsah Aziz, Chow Y. Ping, Hamidah Alias, Nurul-Syakima Ab Mutalib, Rahman Jamal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Subjects:	acute myeloid leukemia mutation adult childhood relapse biomarker
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00897/full

Similar Items

Deep Transcriptome Sequencing of Pediatric Acute Myeloid Leukemia Patients at Diagnosis, Remission and Relapse: Experience in 3 Malaysian Children in a Single Center Study
by: Siti Hawa Osman, et al.
Published: (2020-02-01)

Relapse-specific genetic patterns in the exomic mutational landscape in acute myeloid leukemia
by: Wardah Qureshi, et al.
Published: (2025-03-01)

Convergent epigenetic evolution drives relapse in acute myeloid leukemia
by: Kevin Nuno, et al.
Published: (2024-04-01)

Advances in next-generation sequencing for relapsed pediatric acute lymphoblastic leukemia: current insights and future directions
by: Nur Farhana Mohd Nippah, et al.
Published: (2024-06-01)

A rare presentation of bilateral ophthalmic relapse of pediatric chronic myeloid leukemia: Multimodal imaging and treatment
by: Gaurav Garg, et al.
Published: (2023-01-01)

Treatment of pediatric relapsed and refractory acute myeloid leukemia
by: F. A. Makhacheva, et al.
Published: (2023-05-01)

Myeloid sarcoma in brain and optic nerve presented as a relapse of acute myeloid leukemia: A case report
by: Mais Musleh, et al.
Published: (2024-05-01)

A case of relapsed acute myeloid leukemia mimicking acute otomastoiditis
by: Ivan Negara, et al.
Published: (2024-04-01)

Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
by: Ya B Balzhanova, et al.
Published: (2019-08-01)

Outcome of children with relapsed acute myeloid leukemia improved over time in the Netherlands between 1998 and 2018
by: Jasper J. van de Pol, et al.
Published: (2023-01-01)

Treatment of Childhood Acute Myeloid Leukemia in Bulgaria
by: Burnusuzov Hasan A., et al.
Published: (2018-06-01)

Isolated central nervous system relapse in acute myeloid leukemia: a case report and review of therapeutic challenges
by: Colin Burns, et al.
Published: (2025-10-01)

Clonal Evolution of Acute Myeloid Leukemia with CEBPA Double Mutations after Long-Term Remission: Case Report and a Literature Review
by: Ying Li, et al.
Published: (2019-05-01)

The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions
by: Matteo Piccini, et al.
Published: (2023-05-01)

Cytogenetic and mutational analysis and outcome assessment of a cohort of 284 children with de novo acute myeloid leukemia reveal complex karyotype as an adverse risk factor for inferior survival
by: Xi Chen, et al.
Published: (2021-05-01)

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
by: Chengtao Zhang, et al.
Published: (2023-08-01)

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment
by: Zheng Li, et al.
Published: (2022-02-01)

Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
by: Bhavana Bhatnagar, et al.
Published: (2025-04-01)

Comparative characteristics of quantitative and structural chromosome abnormalities at the time of diagnosis and in relapses of acute myeloid leukemias
by: S.V. Andreieva, et al.
Published: (2025-06-01)

Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
by: Na Zhang, et al.
Published: (2024-05-01)

Acute Promyelocytic Leukemia (APL) Relapsing into AML-M2 with Normal Cytogenetics. A report.
by: Ranjit Kumar Sahoo, et al.
Published: (2014-08-01)

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience
by: Francesco Angotzi, et al.
Published: (2024-04-01)

Simultaneous Central Nervous System and Cutaneous Relapse in Acute Myeloid Leukemia
by: Eros Cerantola, et al.
Published: (2025-07-01)

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma
by: Xiwen Tong, et al.
Published: (2023-08-01)

Efficacy and safety of the combination of decitabine and CHAG priming regimen in the relapsed or refractory acute myeloid leukemia
by: Yan Wu, et al.
Published: (2024-11-01)

Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience
by: Katarzyna Pawinska-Wasikowska, et al.
Published: (2023-12-01)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
by: Jiewen Sun, et al.
Published: (2020-11-01)

Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01)

Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
by: Magda Zidan, et al.
Published: (2013-06-01)

Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia
by: Xuezhu Xu, et al.
Published: (2023-12-01)

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01)

Lineage Switch Subsequently Developed after Isolated Extramedullary Relapse in Children with Acute Myeloid Leukemia
by: Yee Rae Park, et al.
Published: (2023-10-01)

Successful Treatment of Pediatric Acute Myeloid Leukemia Presenting with Hyperbilirubinemia Secondary to Myeloid Sarcoma: A Case Report
by: Hwazen A. Shash, et al.
Published: (2022-11-01)

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
by: Annalisa Ruggeri, et al.
Published: (2016-09-01)

Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01)

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT
by: Zhangjie Chen, et al.
Published: (2023-03-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
by: Bogdan Popescu, et al.
Published: (2019-12-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
by: Maximiliano Cloobs Venezia, et al.
Published: (2022-11-01)

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics
by: Xinyao Ji, et al.
Published: (2024-12-01)

Epidemiological evaluation and survival of children with acute myeloid leukemia
by: Rahuany Velleda de Morais, et al.
Published: (2021-03-01)